Vikram Khurana, MD, PhD
Brigham & Women's Hospital
Dr. Vikram Khurana is a leading neurologist with deep expertise in Parkinson’s disease and related disorders. He has made major contributions to understanding alpha-synuclein biology using model systems ranging from yeast to human stem cells, for example advancing stearoyl co-A desaturase inhibitors)to clinical trial and uncovering new links between alpha-synuclein and mRNA biology. His lab developed inclusionopathy models that closely mimic human a-syn pathology, and innovative computational and network biology frameworks to integrate a-synuclein data from model systems with human genetic and clinical data for patient stratification. He is now PI of the renowned Harvard Biomarkers Study (HBS2.0).